Analytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
Not a peptide but a true growth factor (OP-1): a protein that builds bone and opposes fibrosis in models. The only one of its class to reach the operating room — as an implant for bone non-unions.
Size: 100 mcg
No published analyses yet.
Research, properties and limitations
AI can make mistakes
Titration schedule · reference
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Period / condition | Dose | Escalation |
|---|---|---|
| Phase 1, knee (intra-articular, single dose) | 0.1 mg | Starting dose |
| Phase 1, higher level (intra-articular, single dose) | 0.3 mg | Increase if needed |
| Surgical implant (OP-1, on collagen, local) | 3.5 mg | Maximum in this schedule |
| Preclinical systemic reference (animal) | 30 mcg/kg, twice weekly | – |
Research overview · reference
Below is a short summary of what the authors of published studies reported. It is not medical advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Postoperative adverse events overall | Patients with tibial nonunion: 61 in the collagen-carried rhOP-1 implant group and 61 in the bone-autograft group, followed for up to 24 months | Occurred in all patients (100% — very common on the pharmacy scale, ≥10%); these are postoperative events, not BMP-7-caused reaction rates | [1] |
| Serious adverse events | The same patient groups | 44% of each group (very common, ≥10%); investigators did not attribute them to the grafts | [1] |
FAQ
Find answers to questions about BMP-7 (OP-1) and related materials.
BMP-7 (bone morphogenetic protein 7), also known as OP-1, is not a short peptide but a true growth factor of the TGF-β superfamily: a glycoprotein dimer of about 35 kDa. The active form is the linked pair of molecules, so its manufacture and analytics are "protein", not peptide.
Source / documentationThe signalling logic: one superfamily, opposite branches. TGF-β1 via Smad2/3 is the pro-fibrotic branch; BMP-7 via Smad1/5/8 counteracts it. That gives BMP-7 two lines: orthopaedic (it made its name on bone) and anti-fibrotic — in preclinical kidney models it softened damage and fibrosis. Details are in the BMP-7 monograph in our wiki.
Source / documentationYes — a unique fact. As OP-1 on a collagen carrier, BMP-7 received a US Humanitarian Device Exemption for tibial non-unions — meaning surgeons really used it as an implant. It is the only one of its class to reach the operating room.
Source / documentationNot as an ordinary injectable peptide, but locally — by surgical implantation on a carrier or by intra-articular injection; no systemic human regimen is established. Reference points are in the dosing guide on this page.
Source / documentationThere is no safety profile for use outside surgical and preclinical contexts, so an honest exhaustive list cannot be compiled. A full review of the known data is in the BMP-7 monograph in our wiki.
Source / documentationKeep the dry powder in a dry, dark place at a low temperature; once dissolved, store it in the refrigerator and do not freeze it again. Details are in the BMP-7 guide on this page.
Source / documentationYou can buy BMP-7 right on this page of our store: current prices and stock are shown in the product card. We deliver across Ukraine with Nova Poshta — to a branch, a parcel locker, or by courier. Payment is by card, by crypto (with a 5% discount), or on delivery. The product ships with the certificate of analysis (COA) for its exact batch.
Source / documentationShare your experience
No reviews yet. Tell others what you think of this product.
BMP-7 (bone morphogenetic protein 7), also known as OP-1, is not a short peptide but a full growth factor of the TGF-β superfamily: a glycoprotein dimer of about 35 kDa. The joined pair of molecules is the active form, so its production and analytics are "protein-grade", not peptide-grade.
The signalling logic: one superfamily, opposite branches. TGF-β1 via Smad2/3 is the pro-fibrotic branch; BMP-7 via Smad1/5/8 counteracts it. Hence BMP-7's two research lines: orthopaedic (the protein is most highly expressed in the kidney too, but it made its name on bone) and anti-fibrotic — in preclinical kidney models it softened injury and fibrosis. Details are in the BMP-7 monograph.
A unique fact: as OP-1 on a collagen carrier, BMP-7 received a US Humanitarian Device Exemption for tibial non-unions — meaning surgeons actually used it as an implant. In research it is applied not as an ordinary injectable peptide but locally — by surgical implantation on a carrier or intra-articular injection; no systemic human regimen is established. Reference points are in the dosing guide; the full line is in the anti-fibrosis category.
Every batch is purity-tested by HPLC, and the certificate of analysis (COA) for your exact batch is in our COA archive. Keep the dry powder in a dry, dark place at a low temperature, and the dissolved solution in the refrigerator.